Update on Administration Efforts on COVID-19 | March 23, 2020
Editor’s note: Here are the recent actions from the Trump administration on COVID. Note especially the FDA actions relaxing certain rules for ventilators and other
Editor’s note: Here are the recent actions from the Trump administration on COVID. Note especially the FDA actions relaxing certain rules for ventilators and other
Health, Security, Economic Benefits from Reshoring By Steven L. Byers, PhD and Jeff Ferry With the spreading coronavirus pandemic, Americans are becoming increasingly aware of
Editor’s note: The silver lining in the coronavirus outbreak is that calls for reshoring medical supplies and devices is becoming very strong. Which will help
Excerpt: How did the pharmaceutical industry start sourcing pharmaceuticals in China? After her presentation at the Made in America trade show last month, I met Rosemary
Editor’s note. Dangerous Chinese products brought to you by Amazon. Enabled by section 321 de minimis rule that allows higher value tariff free imports than
Editor’s note: Pharmaceutical ingredients from China are uninspected, contaminated with carcinogens, and often simply ineffective. We need to rebuild this supply chain in the US.
Excerpt: “China’s authoritarian government, size, and anticompetitive intent are more problematic than the ownership structure of the companies in question. The government can fund them, without
Editors note: another case of dangerous pharmaceutical drugs coming in from China. Most active pharmaceutical ingredients come from China, having moved out of the USA.
Editors note: this issue of unsafe imported pharmaceuticals from China is the next big health scare. It will be bigger than the contaminated pet food
Address by Michael Stumo, CEO, the Coalition for a Prosperous America (CPA), to the John William Pope and Jesse Helms Center Foundations. May 11, 2018,